<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ichicsr SYSTEM "http://www.accessdata.fda.gov/xml/icsr-xml-v2.1.dtd">
<ichicsr lang="en">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>30724_111</messagenumb>
		<messagesenderidentifier>VERTEXP2</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151729</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>JP-VERTEX PHARMACEUTICAL INC.-AE-2012-009043</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20130125</transmissiondate>
		<reporttype>2</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20120614</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20130117</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>JP-Vertex Pharmaceuticals Inc.-AE-2012-009043</companynumb>
		<duplicate>1</duplicate>
		<reportduplicate>
			<duplicatesource>Vertex Pharmaceuticals Inc.</duplicatesource>
			<duplicatenumb>JP-Vertex Pharmaceuticals Inc.-AE-2012-009043</duplicatenumb>
		</reportduplicate>
		<primarysource>
			<reporterfamilyname>UNKNOWN</reporterfamilyname>
			<reportercountry>JP</reportercountry>
			<qualification>3</qualification>
			<studyname>Drug Use-Results surveillance</studyname>
			<sponsorstudynumb>Drug Use-Results Surveillance</sponsorstudynumb>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>VERTEXP2</senderorganization>
			<senderdepartment>Global Patient Safety</senderdepartment>
			<sendertitle>Mr.</sendertitle>
			<sendergivename>Sean</sendergivename>
			<senderfamilyname>Darcy</senderfamilyname>
			<senderstreetaddress>130 Waverly Street</senderstreetaddress>
			<sendercity>Cambridge</sendercity>
			<senderstate>MA</senderstate>
			<senderpostcode>02139</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<senderemailaddress>VRTXGPS_SubmissionTracking@vrtx.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>Office of Surveillence and Epidemiology</receiverdepartment>
			<receivertitle>Mr.</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receiverfax>3019183134</receiverfax>
			<receiveremailaddress>roger.goetsch@fda.hhs.gov</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>Y-I</patientinitial>
			<patientonsetage>52</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex>2</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Chronic hepatitis C</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Gastritis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Insomnia</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>WBC DECREASED</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>WBC decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>White blood cell count decreased</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120505</reactionstartdate>
				<reactionfirsttime>17</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>3</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>NEUTROPHIL DECREASED</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Neutrophil count decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Neutrophil count decreased</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120428</reactionstartdate>
				<reactionfirsttime>10</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>3</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1410</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1840</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1890</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Neutrophil count</testname>
				<testresult>920</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1500</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1250</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Neutrophil count</testname>
				<testresult>830</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Neutrophil count</testname>
				<testresult>2760</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1630</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Neutrophil count</testname>
				<testresult>940</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Neutrophil count</testname>
				<testresult>640</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Neutrophil count</testname>
				<testresult>610</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1010</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Neutrophil count</testname>
				<testresult>810</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1670</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1100</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>29.0</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>35.8</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>29.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>43.9</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.3</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>69.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>53.6</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>43.5</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>33.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>31.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>41.0</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>31.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>48.5</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>42.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>4840</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>5130</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>5060</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3160</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3410</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3360</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2250</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>4000</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3050</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2150</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>1910</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>1980</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2480</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2600</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3430</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2600</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>VX-950 (Telaprevir)</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>201917</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Vertex Pharmaceuticals Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>2250</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>40500</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>2250 mg, qd</drugdosagetext>
				<drugdosageform>Tablet</drugdosageform>
				<drugadministrationroute>048</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120522</drugenddate>
				<drugtreatmentduration>35</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>VX-950</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>VX-950 (Telaprevir)</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>201917</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Vertex Pharmaceuticals Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>1500</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>40500</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>1500 mg, qd</drugdosagetext>
				<drugdosageform>Tablet</drugdosageform>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120523</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120711</drugenddate>
				<drugtreatmentduration>50</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>4</actiondrug>
				<activesubstance>
					<activesubstancename>VX-950</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>600</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>600 mg, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120515</drugenddate>
				<drugtreatmentduration>28</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>200 mg, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120516</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120817</drugenddate>
				<drugtreatmentduration>94</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>400</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>400 mg, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120818</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20121002</drugenddate>
				<drugtreatmentduration>46</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>PEGINTRON</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>1.5</drugstructuredosagenumb>
				<drugstructuredosageunit>008</drugstructuredosageunit>
				<drugdosagetext>1.5 &#xc2b5;g/kg, UNK</drugdosagetext>
				<drugadministrationroute>058</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120704</drugenddate>
				<drugtreatmentduration>78</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PEGINTERFERON ALFA-2B</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>PEGINTRON</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit>008</drugstructuredosageunit>
				<drugdosagetext>1.0 &#xc2b5;g/kg, UNK</drugdosagetext>
				<drugadministrationroute>058</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120711</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120926</drugenddate>
				<drugtreatmentduration>78</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PEGINTERFERON ALFA-2B</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>URSO                               /00465701/</medicinalproduct>
				<drugstructuredosagenumb>600</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugdosagetext>600 mg, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>URSODEOXYCHOLIC ACID</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>GASTER D</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>2</drugstructuredosagenumb>
				<drugstructuredosageunit>032</drugstructuredosageunit>
				<drugcumulativedosagenumb>36</drugcumulativedosagenumb>
				<drugcumulativedosageunit>032</drugcumulativedosageunit>
				<drugdosagetext>2 DF, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20121002</drugenddate>
				<drugtreatmentduration>168</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FAMOTIDINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>GASTER D</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>40</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugcumulativedosagenumb>36</drugcumulativedosagenumb>
				<drugcumulativedosageunit>032</drugcumulativedosageunit>
				<drugdosagetext>40 mg, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20121002</drugenddate>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FAMOTIDINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>NABOAL                             /00372302/</medicinalproduct>
				<drugdosagetext>UNK UNK, prn</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120606</drugenddate>
				<drugtreatmentduration>50</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DICLOFENAC SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>ALOSENN                            /00476901/</medicinalproduct>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit>002</drugstructuredosageunit>
				<drugcumulativedosagenumb>.5</drugcumulativedosagenumb>
				<drugcumulativedosageunit>002</drugcumulativedosageunit>
				<drugdosagetext>0.5 g, qd</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120418</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120418</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ACHILLEA MILLEFOLIUM</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>RUBIA TINCTORUM ROOT TINCTURE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SENNA ALEXANDRINA FRUIT</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SENNA ALEXANDRINA LEAF</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>TARAXACUM OFFICINALE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>VOLTAREN                           /00372301/</medicinalproduct>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit>032</drugstructuredosageunit>
				<drugdosagetext>1 DF, prn</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120606</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20121002</drugenddate>
				<drugtreatmentduration>119</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DICLOFENAC</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization>2</drugcharacterization>
				<medicinalproduct>LAXOBERON</medicinalproduct>
				<drugdosagetext>UNK, prn</drugdosagetext>
				<drugadministrationroute>048</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120808</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20120822</drugenddate>
				<drugtreatmentduration>15</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>3</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>SODIUM PICOSULFATE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>The following is a verbatim narrative received from Mitsubishi Tanabe Pharma Corporation:

A 52-year-old female patient was treated with TELAVIC for chronic hepatitis C viremia.

The patient had received monotherapy with interferon.

18 Apr.2012     Therapy with TELAVIC (2250 mg/day), REBETOL (600 mg/day), and PEGINTRON (1.5 mcg/kg/week) was started.

21 Apr.2012     UA increased 1 and UA increased 2 were observed.

27 Apr.2012     The patient complained of appetite impaired 1 and appetite impaired 2 (without particular treatment).

28 Apr.2012     Neutrophil decreased 1, neutrophil decreased 2, platelets decreased 1, and platelets decreased 2 were observed.

5 May.2012     Hb decreased 1, Hb decreased 2, WBC decreased 1, and WBC decreased 2 were observed.

16 May.2012     The dose of REBETOL was changed (200 mg/day).

23 May.2012     The dose of TELAVIC was reduced to 1500 mg per day.

Unknown date    Laboratory test results showed fluctuations in laboratory data, and the dose of only REBETOL was reduced to deal with it.

4 Jul.2012     Neutrophil decreased had exacerbated. The dose of PEGINTRON was reduced. Appetite impaired 2 had resolved.

11 Jul.2012     The dose of PEGINTRON (1.0 mcg/kg/week) was changed. Platelets decreased 1 had resolved.

18 Jul.2012     UA increased 1, and UA increased 2 had resolved.

Unknown date    Neutrophil count, Plt, and UA level had recovered as mentioned above.

24 Jul.2012     Hb decreased 2, WBC decreased 2, neutrophil decreased 2, and platelets decreased 2 were ongoing.

8 Aug.2012     The patient experienced insomnia. The patient complained of sleep loss. LENDORMIN D (0.25 mg/day, until 22 Aug., oral) was prescribed.

18 Aug.2012     The dose of REBETOL was changed to 400 mg per day.

29 Aug.2012      DEPAS (0.5 mg/day, until 2 Oct., oral) was administered additionally. Thereafter it was under control.

26 Sep.2012      Hb decreased, WBC decreased, and neutrophil decreased were ongoing. The administration of PEGINTRON was completed.

2 Oct.2012        Insomnia had resolved.

Reporter's comment Low WBC count was persisting. Even as of 10 Dec.2012, it was still at a low count of 3530.

Follow-up information:

Events "neutrophil decreased 2" and "WBC decreased 2" were deleted. Patient information, drug information, clinical course, laboratory data, and reporter's comment were updated.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr>
